Related Experiment Videos
A postoperative prognostic nomogram for renal cell carcinoma
M W Kattan1, V Reuter, R J Motzer
1Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
The Journal of Urology
|July 4, 2001
Summary
Researchers developed a nomogram to predict recurrence after renal cell carcinoma surgery. This tool aids in patient counseling and clinical trial design for better outcomes.
Area of Science:
- Urology
- Oncology
- Medical Statistics
Background:
- Limited studies combine prognostic factors for renal cell carcinoma (RCC) recurrence prediction post-surgery.
- Accurate prediction is crucial for patient management and treatment planning.
Purpose of the Study:
- To develop and validate a predictive nomogram for the likelihood of recurrence in patients with renal cell carcinoma following nephrectomy.
- To provide a tool for improved patient counseling and clinical trial stratification.
Main Methods:
- Cox proportional hazards regression analysis of pathological data from 601 RCC patients undergoing nephrectomy.
- Inclusion of predictor variables: symptoms (incidental, local, systemic), histology (chromophobe, papillary, conventional), tumor size, and pathological stage.
- Validation using bootstrapping techniques to assess nomogram accuracy and discrimination.
Main Results:
- Disease recurrence observed in 66 out of 601 patients.
- The 5-year probability of freedom from failure for the cohort was 86% (95% CI 82-89).
- The nomogram demonstrated accurate and discriminating predictive capability with an AUC of 0.74.
Conclusions:
- A validated nomogram can predict the 5-year probability of treatment failure in newly diagnosed renal cell carcinoma patients.
- The nomogram is a valuable tool for patient counseling, clinical trial design, and follow-up planning.
- This tool enhances personalized medicine approaches in renal cell carcinoma management.